Extract inhibits enzyme linked to diseases

by Jeff Gelski
Share This:

MOMENCE, ILL. — VitaCurrant black currant extract inhibited Elastase, an enzyme associated with several diseases, up to 96% at a concentration of 0.1%, according to a study conducted at FutureCeuticals, Inc. laboratories. High elastase levels have been associated with disorders such as chronic obstructive pulmonary disease (COPD), cardiovascular disease and ulcerative colitis (UC), according to FutureCeuticals.

FutureCeuticals offers VitaCurrant, a freeze-dried powder that provides 6,000 oxygen radical absorbance capacity (ORAC) units, a measure of antioxidant capacity.

Comment on this Article
We welcome your thoughtful comments. Please comply with our Community rules.



The views expressed in the comments section of Food Business News do not reflect those of Food Business News or its parent company, Sosland Publishing Co., Kansas City, Mo. Concern regarding a specific comment may be registered with the Editor by clicking the Report Abuse link.